Impact of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in cancer patients: a systematic review and meta-analysis of heart failure hospitalisation and mortality.
Event:
ESC Preventive Cardiology 2024
Topic:
Cardio-Oncology
Session:
Managing cardiovascular risk in cancer patients